AAAAAA

   
Results: 1-12 |
Results: 12

Authors: Szczepankiewicz, BG Liu, G Jae, HS Tasker, AS Gunawardana, IW von Geldern, TW Gwaltney, SL Wu-Wong, JR Gehrke, L Chiou, WJ Credo, RB Alder, JD Nukkala, MA Zielinski, NA Jarvis, K Mollison, KW Frost, DJ Bauch, JL Hui, YH Claiborne, AK Li, Q Rosenberg, SH
Citation: Bg. Szczepankiewicz et al., New antimitotic agents with activity in multi-drug-resistant cell lines and in vivo efficacy in murine tumor models, J MED CHEM, 44(25), 2001, pp. 4416-4430

Authors: Jae, HS Winn, M von Geldern, TW Sorensen, BK Chiou, WJ Nguyen, B Marsh, KC Opgenorth, TJ
Citation: Hs. Jae et al., Pyrrolidine-3-carboxylic acids as endothelin antagonists. 5. Highly selective, potent, and orally active ETA antagonists, J MED CHEM, 44(23), 2001, pp. 3978-3984

Authors: Wu-Wong, JR Alder, JD Alder, L Burns, DJ Han, EKH Credo, B Tahir, SK Dayton, BD Ewing, PJ Chiou, WJ
Citation: Jr. Wu-wong et al., Identification and characterization of A-105972, an antineoplastic agent, CANCER RES, 61(4), 2001, pp. 1486-1492

Authors: Chiou, WJ Wessale, JL von Geldern, T Opgenorth, TJ Wu-Wong, JR
Citation: Wj. Chiou et al., 'Irreversible' endothelin-1 binding does not prohibit ABT-627 from reversing endothelin-1-induced effects, J CARDIO PH, 36, 2000, pp. S48-S52

Authors: Wang, JH Chiou, WJ Gagne, GD Wu-Wong, JR
Citation: Jh. Wang et al., Internalization of type-A endothelin receptor, J CARDIO PH, 36, 2000, pp. S61-S65

Authors: Dayton, BD Chiou, WJ Opgenorth, TJ Wu-Wong, JR
Citation: Bd. Dayton et al., Direct determination of endothelin receptor antagonist levels in plasma using a scintillation proximity assay, LIFE SCI, 66(10), 2000, pp. 937-945

Authors: Boyd, SA Mantei, RA Tasker, AS Liu, G Sorensen, BK Henry, KJ von Geldern, TW Winn, M Wu-Wong, JSR Chiou, WJ Dixon, DB Hutchins, CW Marsh, KC Nguyen, E Opgenorth, TJ
Citation: Sa. Boyd et al., Discovery of a series of pyrrolidine-based endothelin receptor antagonistswith enhanced ETA receptor selectivity, BIO MED CH, 7(6), 1999, pp. 991-1002

Authors: Chiou, WJ Wang, JH Berg, CE Wu-Wong, JR
Citation: Wj. Chiou et al., SV40 virus transformation down-regulates endothelin receptor, BBA-MOL CEL, 1450(1), 1999, pp. 35-44

Authors: von Geldern, TW Tasker, AS Sorensen, BK Winn, M Szczepankiewicz, BG Dixon, DB Chiou, WJ Wang, LM Wessale, JL Adler, A Marsh, KC Nguyen, E Opgenorth, TJ
Citation: Tw. Von Geldern et al., Pyrrolidine-3-carboxylic acids as endothelin antagonists. 4. Side chain conformational restriction leads to ETB selectivity, J MED CHEM, 42(18), 1999, pp. 3668-3678

Authors: Liu, G Kozmina, NS Winn, M von Geldern, TW Chiou, WJ Dixon, DB Nguyen, E Marsh, KC Opgenorth, TJ
Citation: G. Liu et al., Design, synthesis, and activity of a series of pyrrolidine-3-carboxylic acid-based, highly specific, orally active ETB antagonists containing a diphenylmethylamine acetamide side chain, J MED CHEM, 42(18), 1999, pp. 3679-3689

Authors: Wu-Wong, JSR Berg, CE Wang, JH Chiou, WJ Fissel, B
Citation: Jsr. Wu-wong et al., Endothelin stimulates glucose uptake and GLUT4 translocation via activation of endothelin ETA receptor in 3T3-L1 adipocytes, J BIOL CHEM, 274(12), 1999, pp. 8103-8110

Authors: Wu-Wong, JSR Dixon, DB Chiou, WJ Dayton, BD Novosad, EI Adler, AL Wessale, JL Calzadilla, SV Hernandez, L Marsh, KC Liu, G Szczepankiewicz, B von Geldern, TW Opgenorth, TJ
Citation: Jsr. Wu-wong et al., Pharmacology of A-216546: a highly selective antagonist for endothelin ETAreceptor, EUR J PHARM, 366(2-3), 1999, pp. 189-201
Risultati: 1-12 |